Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hodgkin's disease
ADR ID BADD_A02083
ADR Hierarchy
01      Blood and lymphatic system disorders
01.16      Lymphomas Hodgkin's disease
01.16.01      Hodgkin's disease NEC
01.16.01.001      Hodgkin's disease
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.31      Lymphomas Hodgkin's disease
16.31.01      Hodgkin's disease NEC
16.31.01.001      Hodgkin's disease
Description A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. [MeSH]
MedDRA Code 10020206
MeSH ID D006689; D006689; D006689
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hodgins | Hodgkin's disease | Hodgkin's disease NOS | Hodgkin's disease, lymphocytic depletion, involving intra-abdominal lymph nodes | Hodgkin's disease, lymphocytic depletion, involving intrapelvic lymph nodes | Hodgkin's disease, lymphocytic depletion, involving intrathoracic lymph nodes | Hodgkin's disease, lymphocytic depletion, involving lymph nodes of axilla and upper limb. | Hodgkin's disease, lymphocytic depletion, involving lymph nodes of head, face, and neck. | Hodgkin's disease, lymphocytic depletion, involving lymph nodes of inguinal region and lower limb | Hodgkin's disease, lymphocytic-histiocytic predominance inv axillary lymph ns | Hodgkin's disease, lymphocytic-histiocytic predominance inv head/neck lymph ns | Hodgkin's disease, lymphocytic-histiocytic predominance inv inguinal lymph ns | Hodgkin's disease, lymphocytic-histiocytic predominance involving intra-abdominal lymph nodes. | Hodgkin's disease, lymphocytic-histiocytic predominance involving intrapelvic lymph nodes. | Hodgkin's disease, lymphocytic-histiocytic predominance involving intrathoracic lymph nodes | Hodgkin's disease, mixed cellularity, involving intra-abdominal lymph nodes | Hodgkin's disease, mixed cellularity, involving intrapelvic lymph nodes | Hodgkin's disease, mixed cellularity, involving intrathoracic lymph nodes | Hodgkin's disease, mixed cellularity, involving lymph nodes of axilla and upper limb. | Hodgkin's disease, mixed cellularity, involving lymph nodes of head, face, and neck. | Hodgkin's disease, mixed cellularity, involving lymph nodes of inguinal region and lower limb. | Hodgkin's disease, nodular sclerosis, involving intra-abdominal lymph nodes | Hodgkin's disease, nodular sclerosis, involving intrapelvic lymph nodes | Hodgkin's disease, nodular sclerosis, involving intrathoracic lymph nodes | Hodgkin's disease, nodular sclerosis, involving lymph nodes of axilla and upper limb. | Hodgkin's disease, nodular sclerosis, involving lymph nodes of head, face, and neck. | Hodgkin's disease, nodular sclerosis, involving lymph nodes of inguinal region and lower limb. | Hodgkin's disease, unspecified type | Hodgkin's granuloma | Hodgkin's lymphoma | Hodgkin's paragranuloma involving intra-abdominal lymph nodes | Hodgkin's paragranuloma involving intrapelvic lymph nodes | Hodgkin's paragranuloma involving intrathoracic lymph nodes | Hodgkin's paragranuloma involving lymph nodes of axilla and upper limb | Hodgkin's paragranuloma involving lymph nodes of head, face, and neck | Hodgkin's paragranuloma involving lymph nodes of inguinal region and lower limb. | Hodgkin's sarcoma involving intra-abdominal lymph nodes | Hodgkin's sarcoma involving intrapelvic lymph nodes | Hodgkin's sarcoma involving intrathoracic lymph nodes | Hodgkin's sarcoma involving lymph nodes of axilla and upper limb | Hodgkin's sarcoma involving lymph nodes of head, face, and neck | Hodgkin's sarcoma involving lymph nodes of inguinal region and lower limb | Lymphogranulomatosis | Hodgkin Disease | Disease, Hodgkin | Granuloma, Hodgkin's | Hodgkin's Granuloma | Granuloma, Hodgkins | Hodgkins Granuloma | Lymphogranuloma, Malignant | Lymphogranulomas, Malignant | Malignant Lymphogranuloma | Malignant Lymphogranulomas | Hodgkin Lymphoma | Lymphoma, Hodgkin | Hodgkin's Disease | Disease, Hodgkin's | Hodgkin's Lymphoma | Hodgkins Lymphoma | Lymphoma, Hodgkin's | Hodgkins Disease | Disease, Hodgkins | Granuloma, Hodgkin | Hodgkin Granuloma | Granuloma, Malignant | Malignant Granuloma | Malignant Granulomas | Nodular Lymphocyte-Predominant Hodgkin's Lymphoma | Nodular Lymphocyte Predominant Hodgkin's Lymphoma | Nodular Sclerosing Hodgkin's Lymphoma | Lymphocyte-Rich Classical Hodgkin's Lymphoma | Lymphocyte Rich Classical Hodgkin's Lymphoma | Mixed Cellularity Hodgkin's Lymphoma | Hodgkin Lymphoma, Adult | Adult Hodgkin Lymphoma | Lymphocyte Depletion Hodgkin's Lymphoma
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00156Apremilast0.000604%
BADD_D00195Azathioprine0.000937%
BADD_D00497Clomiphene--
BADD_D00498Clomiphene citrate--
BADD_D00511Clozapine0.009504%
BADD_D00551Cyclosporine--
BADD_D00586Darunavir0.001622%
BADD_D00589Dasatinib0.000208%
BADD_D00680Dimethyl fumarate0.000478%
BADD_D00723Doxorubicin0.000139%
BADD_D00766Emtricitabine0.002232%
BADD_D00914Fludarabine0.000208%
BADD_D01119Ibrutinib0.000139%
BADD_D01213Isotretinoin0.000329%
BADD_D01253Lenalidomide0.004229%
BADD_D01281Levonorgestrel0.000544%
BADD_D01352Maraviroc0.000377%
BADD_D01366Medroxyprogesterone acetate--
BADD_D01386Mephenytoin--
BADD_D01418Methotrexate0.000657%
BADD_D01765Phenytoin--
BADD_D01766Phenytoin sodium--
BADD_D01834Prednisone0.000016%
BADD_D01835Pregabalin0.000062%
BADD_D02105Tacrolimus0.000370%
BADD_D02165Teriflunomide0.000302%
BADD_D02192Thalidomide--
BADD_D02236Tofacitinib0.000604%
The 1th Page    1    Total 1 Pages